Research and application of science and technology R&D

The research and development (R&D) of new products in the field of vaccines and biological products requires extensive time and significant financial investment in technology, infrastructure, equipment, and human resources. Despite various limitations and challenges in recent years, the determination to engage in collaborative international and domestic research and development activities is a crucial foundation.
This approach aims to move towards technological self-sufficiency or seize opportunities for technology transfer, allowing independent production of vaccines and medical products domestically. This effort contributes to enhancing product quality, reducing production costs, serving the community, and ensuring vaccine and biological product security in disease prevention and treatment, as guided by the Government and the Ministry of Health.
IMG 7239
List of vaccines under research, development, and technology transfer:
  • No.
  • Name of vaccine
  • Type
  • TECHNOLOGY
  • RESULT
01
JECEVAX
Japanese Encephalitis vaccine inactivated on vero cell
Type
Multiple doses and
Single dose
TECHNOLOGY

Bejing-1 strain vaccine produced on Vero cell

RESULT

New technology.
Completion of registration dossier
Expected to be in use in 2025

02
Hemophilus influenza conjugate vaccine
Type
Sell the finished product for the production of the
5-in-1 vaccine
TECHNOLOGY

Polysaccharide conjugate
Protein carrier

RESULT

New technology
Laboratory scale completion

03
COVID-19 vaccine
Type
Single dose
TECHNOLOGY

Vector vaccine

RESULT

Receiving new technology transfer

Total: 03 products
List of imported vaccine products with technology transfer from 2024 and in the future:
  • No.
  • Name of vaccine
  • Type
  • TECHNOLOGY
  • RESULT
01
PNEUMOSIL
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (10-Valent)
Type
Multiple doses and
Single dose
TECHNOLOGY

Polysaccharide
Conjugate Protein Carrier
(new technology transfer)

RESULT

Completion of registration dossier Expected for use in 2025
Transfer and master of production technology from 2026-2030

02
RABIVAX-S
Rabies Vaccine Inactivated (Freeze-Dried)
Type
Single dose
TECHNOLOGY

Vaccine produced on Vero cell
(new technology transfer)

RESULT

Completion of registration dossier Expected for use in 2024
Transfer and master of production technology from 2026-2030

03
SKYVaricella Inj.
(Varicella Virus Vaccine (live) [Oka/SK])
Type
Single dose
TECHNOLOGY

Live attenuated vaccine
(technology transfer)

RESULT

Completion of registration dossier.
Expected for use in 2024.
Transfer and master of production technology from 2026-2030

04
Hand, Foot and Mouth Disease Vaccine (EV71)
Type
Single dose
TECHNOLOGY

Inactivated vaccine on Vero cell

RESULT

Transfer and master of production technology from 2025-2030

05
HPV 4-valent vaccine
Type
Multiple doses and
Single dose
TECHNOLOGY

Virus Like Particles

RESULT

Transfer and master of production technology from 2026-2030.

Total: 05 products